With respect to the impact of molecular genetics on survival in patients with EM AML, although mutations of TP53 (7/225, 3.1%) and IKZF1 (9/225, 4.0%) were rare, both alterations were significantly associated with decreased EFS and OS. Here, TP53 is linked to acute myeloid leukemia.